The Interplay Between Insulin Resistance, Affective Dysregulation, and Binge Eating in Obesity: Toward an Integrated Biopsychosocial Treatment Model
Obesities · 03.01.2026 · 6 (1) · 1
DOI: 10.3390/obesities6010001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesities, online erschienen am 03.01.2026. Verfasst von Luna Carpinelli und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Obesity is increasingly recognized as a complex condition characterized by the convergence of metabolic dysregulation and psychological vulnerability. Insulin resistance (IR) has been identified as a biological bridge linking metabolic imbalance with affective symptoms such as anxiety, depression, and disordered eating behaviors.
Methods
Fifteen obese adults (mean age = 25 ± 4.3 years) were evaluated through clinical examination, anthropometric assessment (BMI), biochemical assays (fasting insulin, AST, ALT), and standardized psychological assessments (STAI, BDI-II). In parallel, a rapid systematic review (2019–2025) synthesized evidence on the association between IR, affective dysregulation, binge eating disorder (BED), and the clinical role of insulin-sensitizing or incretin-based therapies.
Results
Participants exhibited marked hyperinsulinemia (M = 79 μU/mL, SD = 6.61) and elevated anxiety (STAI-Trait = 54.22 ± 22.4) and depression scores (BDI-II = 21.6 ± 7.5). Liver enzymes were within normal limits. Literature synthesis confirmed consistent associations between IR, mood symptoms, and BED, associated with biological processes including inflammation, HPA axis hyperactivity, and dopaminergic imbalance. Integrated treatment approaches combining cognitive-behavioral therapy, medical nutrition therapy, and insulin-sensitizing agents (metformin, GLP-1RA, and GLP-1/GIP RA) were supported as effective and safe options.
Conclusions
The coexistence of insulin resistance and emotional dysregulation in obesity is consistent with the hypothesis of a bidirectional metabolic–emotional axis. Early, integrated interventions addressing both metabolic and psychological domains may improve clinical outcomes and reduce progression toward chronic metabolic and psychiatric comorbidity.
Zitieren
APA
Carpinelli, L., Amato, C., Marinelli, D. A., Stornaiuolo, G., & Savarese, G. (2026). The Interplay Between Insulin Resistance, Affective Dysregulation, and Binge Eating in Obesity: Toward an Integrated Biopsychosocial Treatment Model. Obesities, 6(1), 1. https://doi.org/10.3390/obesities6010001
Vancouver
Carpinelli L, Amato C, Marinelli DA, Stornaiuolo G, Savarese G. The Interplay Between Insulin Resistance, Affective Dysregulation, and Binge Eating in Obesity: Toward an Integrated Biopsychosocial Treatment Model. Obesities. 2026;6(1):1. doi:10.3390/obesities6010001
BibTeX
@article{Carpinelli2026,
author = {Carpinelli, Luna and Amato, Carolina and Marinelli, Daniela Abate and Stornaiuolo, Giovanna and Savarese, Giulia},
title = {The Interplay Between Insulin Resistance, Affective Dysregulation, and Binge Eating in Obesity: Toward an Integrated Biopsychosocial Treatment Model},
journal = {Obesities},
year = {2026},
volume = {6},
number = {1},
pages = {1},
doi = {10.3390/obesities6010001}
}
EUVIMED